Study of Belantamab Mafodotin in Combination With Kd for the Treatment of Relapsed Myeloma Patients, Refractory to Lenalidomide
Clinical trial NCT05060627 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05060627
- Sponsor
- PETHEMA Foundation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-20
- Primary completion
- 2024-10-23
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.